TY - JOUR
T1 - European Thyroid Association (ETA) and Thyroid Federation International (TFI) Joint Position Statement on the Interchangeability of Levothyroxine Products in EU Countries
AU - Fliers, Eric
AU - Demeneix, Barbara
AU - Bhaseen, Ashok
AU - Brix, Thomas H.
PY - 2018
Y1 - 2018
N2 - Several European countries have seen major health issues after a switch from one levothyroxine brand to another, as well as following the introduction of several levothyroxine formulation changes. While the relationship between these health issues and brand or formulation changes merits further investigation, the current position statement on behalf of both health-care providers and patients summarizes recent events in several European countries and provides a number of recommendations to limit the burden for patients, so as to prevent increased health-care consumption and health-care expenses in this context.
AB - Several European countries have seen major health issues after a switch from one levothyroxine brand to another, as well as following the introduction of several levothyroxine formulation changes. While the relationship between these health issues and brand or formulation changes merits further investigation, the current position statement on behalf of both health-care providers and patients summarizes recent events in several European countries and provides a number of recommendations to limit the burden for patients, so as to prevent increased health-care consumption and health-care expenses in this context.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85054513170&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30374426
U2 - https://doi.org/10.1159/000493123
DO - https://doi.org/10.1159/000493123
M3 - Review article
C2 - 30374426
SN - 2235-0640
VL - 7
SP - 238
EP - 242
JO - European thyroid journal
JF - European thyroid journal
IS - 5
ER -